None
Quote | iBio Inc. (NYSE:IBIO)
Last: | $1.89 |
---|---|
Change Percent: | -4.06% |
Open: | $2.03 |
Close: | $1.97 |
High: | $2.03 |
Low: | $1.85 |
Volume: | 63,487 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | iBio Inc. (NYSE:IBIO)
2024-07-05 08:10:22 ET More on iBio Seeking Alpha’s Quant Rating on iBio Historical earnings data for iBio Financial information for iBio Read the full article on Seeking Alpha For further details see: iBio files $150M mixed shelf offering
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
Message Board Posts | iBio Inc. (NYSE:IBIO)
Subject | By | Source | When |
---|---|---|---|
$IBIO iBio Inc | mick | investorshub | 04/30/2023 11:14:27 PM |
Printing $1.19 | redspeed | investorshub | 04/24/2023 2:29:40 PM |
Tutes came and go... | JPetroInc | investorshub | 04/23/2023 12:38:12 AM |
Aww, isn't THAT cute, Juliet... Or Janet... Probably | DRHUMI | investorshub | 04/22/2023 1:22:16 AM |
this ain't Enzolytics... | JPetroInc | investorshub | 04/22/2023 12:43:47 AM |
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...